Cargando…

Linking Pluripotency Reprogramming and Cancer

Tumor development and the generation of induced pluripotent stem cells are highly comparable processes with striking similarities. Cellular plasticity is inherent to tumor evolution, rendering cells that acquire a stem cell‐like phenotype, for which Sox2 activation has proved instrumental for the pl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iglesias, Juan Manuel, Gumuzio, Juan, Martin, Angel G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442824/ https://www.ncbi.nlm.nih.gov/pubmed/28191771 http://dx.doi.org/10.5966/sctm.2015-0225

Ejemplares similares

Suppression of SIRT2 and altered acetylation status of human pluripotent stem cells: possible link to metabolic switch during reprogramming
por: Kwon, Ok-Seon, et al.
Publicado: (2017)

The Activation of the Sox2 RR2 Pluripotency Transcriptional Reporter in Human Breast Cancer Cell Lines is Dynamic and Labels Cells with Higher Tumorigenic Potential
por: Iglesias, Juan Manuel, et al.
Publicado: (2014)

Mitochondrial fusion by pharmacological manipulation impedes somatic cell reprogramming to pluripotency: New insight into the role of mitophagy in cell stemness
por: Vazquez-Martin, Alejandro, et al.
Publicado: (2012)

Epigenetic reprogramming in small cell lung cancer
por: Chen, Jingyao, et al.
Publicado: (2022)

Snapshots of Pluripotency
por: Tesar, Paul J.
Publicado: (2016)

Induced pluripotent stem cells are induced pluripotent stem cell-like cells
por: Song, Liting, et al.
Publicado: (2015)

Epigenomic reprogramming in peripheral nerve injury
por: Ma, Ki H., et al.
Publicado: (2016)

Aspartame Not Linked to Cancer
por: Abegaz, Eyassu G.
Publicado: (2007)

Neuroregeneration using in vivo cellular reprogramming
por: Nguyen, Tu, et al.
Publicado: (2017)

Organelle remodeling in somatic cell reprogramming
por: Liu, Yang, et al.
Publicado: (2020)

Transcriptomic reprogramming for neuronal age reversal
por: Plesa, Alexandru M., et al.
Publicado: (2023)

Linking Incomplete Reprogramming to the Improved Pluripotency of Murine Embryonal Carcinoma Cell-Derived Pluripotent Stem Cells
por: Chang, Gang, et al.
Publicado: (2010)

Five Classic Articles in Somatic Cell Reprogramming
por: Park, In-Hyun
Publicado: (2010)

Reprogramming the Methylome: Erasing Memory and Creating Diversity
por: Lee, Heather J., et al.
Publicado: (2014)

Molecular versatility during pluripotency progression
por: Furlan, Giacomo, et al.
Publicado: (2023)

Cellular reprogramming and inherited peripheral neuropathies: perspectives and challenges
por: Saporta, Mario A.
Publicado: (2015)

In vivo astrocyte reprogramming following spinal cord injury
por: Gerber, Yannick N., et al.
Publicado: (2023)

Molecular mechanisms of pluripotency and reprogramming
por: Na, Jie, et al.
Publicado: (2010)

The Art of Capturing Pluripotency: Creating the Right Culture
por: Ying, Qi-Long, et al.
Publicado: (2017)

The Tumorigenic Potential of Human Pluripotent Stem Cells
por: Lezmi, Elyad, et al.
Publicado: (2022)

Metabostemness: Metaboloepigenetic reprogramming of cancer stem-cell functions
por: Menendez, Javier A., et al.
Publicado: (2014)

Deciphering the roadmap of in vivo reprogramming toward pluripotency
por: Chondronasiou, Dafni, et al.
Publicado: (2022)

AAV vector-mediated in vivo reprogramming into pluripotency
por: Senís, Elena, et al.
Publicado: (2018)

Contributions of Mammalian Chimeras to Pluripotent Stem Cell Research
por: Mascetti, Victoria L., et al.
Publicado: (2016)

Adult neurogenesis and in vivo reprogramming: combining strategies for endogenous brain repair
por: Jones, Kathryn S., et al.
Publicado: (2016)

In vivo direct reprogramming as a therapeutic strategy for brain and retina repair
por: Sekiryu, Haruka, et al.
Publicado: (2021)

MicroRNA‐mediated metabolic reprogramming of chimeric antigen receptor T cells
por: Rad, Seyed Mohammad Ali Hosseini, et al.
Publicado: (2022)

A Standard Nomenclature for Referencing and Authentication of Pluripotent Stem Cells
por: Kurtz, Andreas, et al.
Publicado: (2018)

Human pluripotent reprogramming with CRISPR activators
por: Weltner, Jere, et al.
Publicado: (2018)

Somatic Reprogramming—Above and Beyond Pluripotency
por: Meir, Yaa-Jyuhn James, et al.
Publicado: (2021)

Induced pluripotent stem cells for modeling and cell therapy of Parkinson's disease
por: Csöbönyeiová, Mária, et al.
Publicado: (2016)

Obtaining Consent for Future Research with Induced Pluripotent Cells: Opportunities and Challenges
por: Aalto-Setälä, Katriina, et al.
Publicado: (2009)

Studying neurological disorders using induced pluripotent stem cells and optogenetics
por: Chin, Eunice W.M., et al.
Publicado: (2015)

Novel pluripotent stem cell lines for enriched grafting in Parkinson’s disease
por: Cota-Coronado, Agustin, et al.
Publicado: (2019)

Prospects for the Use of Induced Pluripotent Stem Cells in Animal Conservation and Environmental Protection
por: Stanton, Morgan M., et al.
Publicado: (2018)

Pluripotent stem cell derived inhibitory interneurons – principles and applications in health and disease
por: Keefe, Francesca, et al.
Publicado: (2019)

History and current status of clinical studies using human pluripotent stem cells
por: Kobold, Sabine, et al.
Publicado: (2023)

Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells
por: Corominas-Faja, Bruna, et al.
Publicado: (2014)

DNA methylation reprogramming in medaka fish, a promising animal model for environmental epigenetics research
por: Wang, Xuegeng, et al.
Publicado: (2020)

Metabolic reprogramming of glial cells as a new target for central nervous system axon regeneration
por: Walden, Erin L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4u2ifbr2s07urq5iv2b47t94dk